NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD)

Clinical trials for NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD) explained in plain language.

Never miss a new study

Get alerted when new NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD) trials appear

Sign up with your email to follow new studies for NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New eye injection study aims to protect vision with fewer shots

Disease control Not yet recruiting

This study is testing two different treatment schedules for an eye injection (aflibercept 8mg) to control a serious eye condition called Polypoidal Choroidal Vasculopathy (PCV), which can cause vision loss. It will enroll 174 Chinese patients who have not received prior treatment…

Matched conditions: NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD)

Phase: PHASE4 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD)

Get alerted when new NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD) trials appear

New eye injection study aims to protect vision with fewer shots